Аннотация:Biochemical methods have shown the interaction of the peptide Semax with high molecular-weight heparin to give rise a complex compound. A procedure has been developed to derive the complex from homogenous heparin and peptide agents. The complex has anticoagulant and fibrinolytic properties in vitro conditions and in vivo when intravenously and intranasal injected.
Semax in combination with heparin in particular may be a promising antithrombotic agent.